The National Institutes of Health (NIH) is offering a funding opportunity through the Notice of Funding Opportunity (NOFO) titled "Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)." This initiative aims to support revision applications from currently funded NCI R01 research projects, encouraging researchers to integrate innovative technologies developed through the NCI Innovative Molecular Analysis Technologies (IMAT) program into their ongoing studies to enhance cancer research. The NIH plans to award up to three grants totaling $600,000 for fiscal year 2025, with individual project budgets capped at $150,000 annually, and applications must be submitted via Grants.gov by October 1, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.